Trademark Details For MYQUISTA (Serial Number 97703857)

  •  Home
  •  Print
MYQUISTA
1
3
2
0
Serial Number  United States - USPTO 97703857
Registration Number -
Mark
MYQUISTA
Filing Date Dec-05-2022
Status
Pending  
FIRST EXTENS.. (730)
FIRST EXTENSION - GRANTED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLaurence Rickles TEVA PHARMACEUTICALS USA, INC.
Address400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-08-2022NEW APPLICATION ENTERED   NWAPI
Dec-08-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Sep-12-2023ASSIGNED TO EXAMINER   DOCKD
Sep-13-2023NON-FINAL ACTION WRITTEN   CNRTR
Sep-13-2023NON-FINAL ACTION E-MAILED   GNRTF
Sep-13-2023NOTIFICATION OF NON-FINAL ACTION E-MAILED   GNRNO
Oct-24-2023TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Oct-24-2023CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Oct-25-2023TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Oct-26-2023SUSPENSION LETTER WRITTEN   CNSLR
Oct-26-2023LETTER OF SUSPENSION E-MAILED   GNSLS
Oct-26-2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED   GNS3O
Apr-26-2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION   RCCKS
May-16-2024APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
May-29-2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Jun-18-2024PUBLISHED FOR OPPOSITION   PUBOA
Jun-18-2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Aug-13-2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Dec-18-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Dec-18-2024SOU EXTENSION 1 FILED   EXT1S
Dec-18-2024SOU EXTENSION 1 GRANTED   EX1GS
Dec-18-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE